During the past decade, Yale-New Haven Hospital North Haven Medical Center conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 22 clinical trials were completed, i.e. on average, 31% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 20 clinical trials were completed. i.e. 90.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yale-New Haven Hospital North Haven Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 34 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored and "NRG Oncology" with 8 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale-New Haven Hospital North Haven Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "American College of Radiology Imaging Network" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Yale-New Haven Hospital North Haven Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (5 trials), "Stage II Breast Cancer" (4 trials) and "Stage IIIA Breast Cancer" (4 trials). Many other conditions were trialed in "Yale-New Haven Hospital North Haven Medical Center" in a lesser frequency.

Most popular intervention types in "Yale-New Haven Hospital North Haven Medical Center" are "Drug" (64 trials), "Other" (55 trials), "Biological" (42 trials), "Procedure" (23 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Quality-of-Life Assessment" (21 trials), "Computed Tomography" (16 trials), "Biospecimen Collection" (14 trials) and "Questionnaire Administration" (12 trials). Other intervention names were less common.

The vast majority of trials in "Yale-New Haven Hospital North Haven Medical Center" are 68 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Yale-New Haven Hospital North Haven Medical Center". undefined are not yet recruiting, 23 are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Yale-New Haven Hospital North Haven Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Yale-New Haven Hospital North Haven Medical Center, 5 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".